(191 days)
No
The description focuses on image processing techniques (BLI, LCI, FICE) and tissue oxygen saturation measurement (OXEI), which are described as proprietary software and color-coded digital images, not explicitly mentioning or implying the use of AI or ML algorithms for these functions. The performance studies also do not describe AI/ML model training or validation.
Yes
The intended use states that the device is for "treatment." Specifically, the Light Source BL-7000X is used for "treatment" (therapy) by providing illumination and air supply to an endoscope.
Yes
Explanation: The VP-7000 and BL-7000X are used for "endoscopic observation, diagnosis, treatment, and image recording." The Image Processing Unit EX-0 is specifically mentioned as "an optional module intended for use as an adjunctive monitor of the hemoglobin oxygen saturation of blood in superficial tissue of the endoscopic observation image area in patients at risk for ischemic states," which provides diagnostic information. The system is also used for "visualization of tissue oxygen saturation (StO2) levels."
No
The device description clearly outlines multiple hardware components (Processor VP-7000, Light Source BL-7000X, Image Processing Unit EX-0) with physical dimensions, power requirements, and specific functions beyond just software processing. While software is mentioned for image enhancement, it is integrated within these hardware units.
Based on the provided information, the Processor VP-7000 and Light Source BL-7000X are NOT IVD (In Vitro Diagnostic) devices.
Here's why:
- IVD Definition: In Vitro Diagnostic devices are used to examine specimens derived from the human body (like blood, urine, tissue) outside the body to provide information for diagnosis, monitoring, or screening.
- Device Function: The VP-7000 and BL-7000X are part of an endoscopic system. Their primary function is to facilitate in vivo (within the living body) observation, diagnosis, and treatment by providing illumination and processing images from inside the body.
- Intended Use: The intended use clearly states "for endoscopic observation, diagnosis, treatment, and image recording." This is an in vivo application.
- Specimen Type: The devices work with images and light from within the body, not with specimens taken from the body.
- Optional Module EX-0: While the optional Image Processing Unit EX-0 monitors hemoglobin oxygen saturation in superficial tissue of the endoscopic observation image area, this is still an in vivo measurement based on light interaction within the tissue, not an analysis of a specimen taken from the body.
Therefore, the described devices are considered medical devices used for in vivo procedures, not IVDs.
N/A
Intended Use / Indications for Use
Processor VP-7000:
The VP-7000 unit is used for endoscopic observation, diagnosis, treatment, and image recording. It is intended to process electronic signals transmitted from a video endoscope (a video camera in an endoscope).
This product may be used on all patients requiring endoscopic examination and when using a Fujinon/FUJIFILM medical endoscope and light source together with montor, recorder and various peripheral devices. BLI (Blue Light Imaging), LCI (Linked Color Imaging) and FICE (Flexible spectral-Imaging Color Enhancement) are adjunctive tools for gastrointestinal endoscopic examination which can be used to supplement Fujifilm white light endoscopy. BLI, LCI and FICE are not intended to replace histopathological sampling as a means of diagnosis.
The Image Processing Unit EX-0 is an optional module intended for use as an adjunctive monitor of the hemoglobin oxygen saturation of blood in superficial tissue of the endoscopic observation image area in patients at risk for ischemic states.
This product may be used on all patients requiring endoscopic examination when using a Fujinon/FUJIFILM medical endoscope, video processor and light source together with monitor, recorder and various peripheral devices.
The prospective clinical value of measurements made with OXEI has not been demonstrated in disease states.
Light Source BL-7000X:
The BL-700X Light Source is used for endoscopic observation, diagnosis, treatment, and image recording, It is intended to provide illumination to an endoscope. The light source also functions as a pump to supply air through the endoscope while inside the body to assist in obtaining clear visualization to facilitate diagnostic examination.
This product may be used on all patients requiring endoscopic examination and when using a Fujinon/FUJIFILM medical endoscope and video processor together with monitor, recorder and various peripheral devices.
Product codes
GCJ, FET, NTN, PEA, MUD, NWB
Device Description
Processor VP-7000 relays the image from the endoscope to a video monitor. Projection can be either analog or digital at the user's preference. VP-7000 also incorporates internal digital storage capacity. VP-7000 controls the light projected to the body cavity. VP-7000 provides for optional structural enhancement through user modes FICE (Flexible spectral-Imaging Color Enhancement), BLI (Blue Light Imaging), BLI-brt (Blue Light Imaging-Bright) and LCI (Linked Color Imaging) at the user's option. Spectral and structural enhancements are achieved through proprietary software. The device is AC operated at a power setting of 120V/60Hz, 0.8A. VP-7000 is housed in a steel-polycarbonate case measuring 390x485x110mm. Optional Image Processing Unit EX-0 receives image data from the VP-7000, and displays an OXEI image on a LCD monitor. The OXEI image is a color-coded digital image showing tissue oxygen saturation (StO2). EX-0 incorporates an internal digital storage capacity. The device is AC-operated at a power setting of 120V/60Hz, 1.0A. EX-0 is housed in a steel-polycarbonate case measuring 320x165x340 mm.
The Fujifilm endoscopes employ fiber bundles to transmit light from Light Source BL-7000X and subsequently to the body cavity. BL-7000X employs five LED lamps. Brightness control is performed by the user. The device is AC operated at a power setting of 120V / 60Hz 1.2A. BL-7000X is housed in a steel polycarbonate case measuring 395x485x155mm.
Processor VP-7000, Light Source BL-7000X, and Image Processing Unit EX-0 are used as a system in conjunction with a compatible video laparoscope or endoscope for visualization of tissue oxygen saturation (StO2) levels.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Video endoscopy
Anatomical Site
gastrointestinal, superficial tissue
Indicated Patient Age Range
all patients
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
The StO2 measurement function was evaluated via comparative bench testing and animal testing.
Bench testing:
StO2 measurement performance of the subject and reference devices was compared with a dissolved oxygen meter as a gold standard using 7 different blood-based phantoms, simulating the optical properties of different tissues that may be monitored by the subject device. The subject device was used in combination with the Video Laparoscope EL-R740M, Endoscope EC-740T/L and EG-740N to measure the StO2 level. Results demonstrated that the subject device performs comparably to the reference device, T-Stat (K081233), with respect to monitoring StO2 levels.
Animal Testing: Three animal studies were conducted: one laparoscopic (Study 1), one endoscopic (Study 2) and one for open surgery (Study 3).
Study 1: A visualization study was conducted to measure the tissue oxygenation saturation (StO2). This study used the subject and reference devices in a laparoscopic manner to look at the serosal surface of the stomach, small intestine, and large intestine. The variability between the subject and reference devices was approximately 29.8%, potentially due to the StO2 variability within the observed tissues. Variability in these measurements has also been reported in the literature. Additionally, limited images were provided to be able to assess the visualization of the device. However, adequate images were provided from this study to show visualization of the device, as well as the StO2 overlay, which were considered acceptable.
Study 2: Tissue oxygen saturation (StO2) in the large intestine and stomach for mucosal tissue was measured endoscopically in 4 female Göttingen minipigs at 11 months of age under general anesthesia with decreased arterial oxygen saturation (SpO2) from 100% to 60%. A correlation of the results with the reference device was compared for performance evaluation. Comparative StO2 measurement performance was evaluated in the swine to simulate clinically-relevant usage of the subject and reference devices. The results of this study demonstrated that the subject device could monitor/measure StO2 levels in a clinically relevant setting.
Study 3: Comparative StO2 measurement performance was evaluated when the subject and reference devices measured StO2 at the same locations under controlled conditions in the open surgery setting where the abdomen was incised and the tissues were exposed and fixed to minimize tissue movement. The StO2 measurement was performed at five parts of the GI tract of each of the three swine including the serosal surface of the stomach, small intestine, and large intestine and the mucosal surface of the stomach and large intestine. Difference in the StO2 readings between the subject and reference devices were analyzed at each part. Measurements of the StO2 were evaluated by the subject and reference devices, which has differences up to 11.4%. The results of this study demonstrated that the subject device measures/monitors the StO2 comparably to the reference device, similar to the bench testing.
The combination of these three studies established that the EX-0 device may be used as an adjunctive monitor of the hemoglobin oxygenation of blood in superficial tissue.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
FUJIFILM Video Processor VP-7000 and Light Source BL-7000 (K192918)
Reference Device(s)
T-Stat 303 Microvascular Tissue Oximeter (K081233)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 876.1500 Endoscope and accessories.
(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.
0
Image /page/0/Picture/0 description: The image shows the logo of the U.S. Food & Drug Administration (FDA). The logo consists of two parts: the Department of Health & Human Services logo on the left and the FDA logo on the right. The FDA logo is in blue and includes the letters "FDA" in a square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in a sans-serif font.
June 30, 2021
FUJIFILM Corporation % Jeffrey Wan Senior Regulatory Affairs Specialist Fujifilm Medical Systems U.S.A., Inc. 81 Hartwell Avenue, Suite 300 Lexington, Massachusetts 02421
Re: K203717
Trade/Device Name: Processor VP-7000, Light Source BL-7000X, Image Processing Unit EX-0 Regulation Number: 21 CFR 876.1500 Regulation Name: Endoscope and Accessories Regulatory Class: Class II Product Code: GCJ, FET, NTN, PEA, MUD, NWB Dated: June 29, 2021 Received: June 29, 2021
Dear Jeffrey Wan:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database located at https://www.accessdata.fda.gov/scripts/cdth/cfdocs/cfpmn/pmn.cfm combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803) for devices or postmarketing safety reporting (21 CFR 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-devices/medical-device-safety/medical-device-reporting-mdr-howreport-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) CDRH Leam (https://www.fda.gov/training-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See (https://www.fda.gov/medical-devices/device-advice-comprehensive-regulatorythe DICE website assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely.
Long Chen, Ph.D. Assistant Director DHT4A: Division of General Surgery Devices OHT4: Office of Surgical and Infection Control Devices Office of Product Evaluation and Ouality Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K203717
Device Name
FUJIFILM Processor VP-7000, Light Source BL-7000X, and Image Processing Unit EX-0
Indications for Use (Describe) Processor VP-7000:
The VP-7000 unit is used for endoscopic observation, diagnosis, treatment, and image recording. It is intended to process electronic signals transmitted from a video endoscope (a video camera in an endoscope).
This product may be used on all patients requiring endoscopic examination and when using a Fujinon/FUJIFILM medical endoscope and light source together with montor, recorder and various peripheral devices. BLI (Blue Light Imaging), LCI (Linked Color Imaging) and FICE (Flexible spectral-Imaging Color Enhancement) are adjunctive tools for gastrointestinal endoscopic examination which can be used to supplement Fujifilm white light endoscopy. BLI, LCI and FICE are not intended to replace histopathological sampling as a means of diagnosis.
The Image Processing Unit EX-0 is an optional module intended for use as an adjunctive monitor of the hemoglobin oxygen saturation of blood in superficial tissue of the endoscopic observation image area in patients at risk for ischemic states.
This product may be used on all patients requiring endoscopic examination when using a Fujinon/FUJIFILM medical endoscope, video processor and light source together with monitor, recorder and various peripheral devices.
The prospective clinical value of measurements made with OXEI has not been demonstrated in disease states.
Light Source BL-7000X:
The BL-700X Light Source is used for endoscopic observation, diagnosis, treatment, and image recording, It is intended to provide illumination to an endoscope. The light source also functions as a pump to supply air through the endoscope while inside the body to assist in obtaining clear visualization to facilitate diagnostic examination.
This product may be used on all patients requiring endoscopic examination and when using a Fujinon/FUJIFILM medical endoscope and video processor together with monitor, recorder and various peripheral devices.
Type of Use (Select one or both, as applicable)
X Prescription Use (Part 21 CFR 801 Subpart D)
Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
3
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
510(k) SUMMARY FUJIFILM Corporation Processor VP-7000, Light Source BL-7000X, and Image Processing Unit EX-0
Date: June 30, 2021
Submitter's Information:
FUJIFILM Corporation 798 Miyanodai Kaisei-Machi Ashigarakami-Gun, Kanagawa, Japan 258-8538
Contact Person:
Jeffrey Wan Manager, Regulatory Affairs Telephone: (201) 675-8947 E-Mail: jeffrey.wan@fujifilm.com
ldentification of the Subject Device:
| Device Name: | Processor VP-7000, Light Source BL-7000X, Image
Processing Unit EX-0 |
|------------------------------|-------------------------------------------------------------------------|
| Common Name: | Endoscopic Video Imaging System/Component |
| Review Panel: | General & Plastic Surgery |
| Regulation Number: | 21 CFR 876.1500 |
| Device Class: | Class II |
| Classification Product Code: | GCJ |
| Subsequent Product Codes: | MUD, FET, NTN, NWB, PEA |
Predicate Device:
- FUJIFILM Video Processor VP-7000 and Light Source BL-7000 (K192918)
Reference Device:
- T-Stat 303 Microvascular Tissue Oximeter (K081233)
Intended Use / Indications for Use
VP-7000
The VP-7000 unit is used for endoscopic observation, diagnosis, treatment, and image recording. It is intended to process electronic signals transmitted from a video endoscope (a video camera in an endoscope).
This product may be used on all patients requiring endoscopic examination and when using a Fujinon/FUJIFILM medical endoscope and light source together with monitor, recorder and various
5
peripheral devices. BLI (Blue Light Imaging), LCI (Linked Color Imaging) and FICE (Flexible spectral-Imaging Color Enhancement) are adjunctive tools for gastrointestinal endoscopic examination which can be used to supplement Fuiifilm white light endoscopy. BLL LCI and FICE are not intended to replace histopathological sampling as a means of diagnosis.
The Image Processing Unit EX-0 is an optional module intended for use as an adjunctive monitor of the hemoglobin oxygen saturation of blood in superficial tissue of the endoscopic observation image area in patients at risk for ischemic states.
This product may be used on all patients requiring endoscopic examination when using a Fujinon/FUJIFILM medical endoscope, video processor and light source together with monitor, recorder and various peripheral devices.
The prospective clinical value of measurements made with OXEI has not been demonstrated in disease states.
BL-7000X
The BL-700X Light Source is used for endoscopic observation, diagnosis, treatment, and image recording. It is intended to provide illumination to an endoscope. The light source also functions as a pump to supply air through the endoscope while inside the body to assist in obtaining clear visualization to facilitate diagnostic examination.
This product may be used on all patients requiring endoscopic examination and when using a Fujinon/FUJIFILM medical endoscope and video processor together with monitor, recorder and various peripheral devices.
Device Description
Processor VP-7000 relays the image from the endoscope to a video monitor. Projection can be either analog or digital at the user's preference. VP-7000 also incorporates internal digital storage capacity. VP-7000 controls the light projected to the body cavity. VP-7000 provides for optional structural enhancement through user modes FICE (Flexible spectral-Imaging Color Enhancement), BLI (Blue Light Imaging), BLI-brt (Blue Light Imaging-Bright) and LCI (Linked Color Imaging) at the user's option. Spectral and structural enhancements are achieved through proprietary software. The device is AC operated at a power setting of 120V/60Hz, 0.8A. VP-7000 is housed in a steel-polycarbonate case measuring 390x485x110mm. Optional Image Processing Unit EX-0 receives image data from the VP-7000, and displays an OXEI image on a LCD monitor. The OXEI image is a color-coded digital image showing tissue oxygen saturation (StO2). EX-0 incorporates an internal digital storage capacity. The device is AC-operated at a power setting of 120V/60Hz, 1.0A. EX-0 is housed in a steel-polycarbonate case measuring 320x165x340 mm.
The Fujifilm endoscopes employ fiber bundles to transmit light from Light Source BL-7000X and subsequently to the body cavity. BL-7000X employs five LED lamps. Brightness control is performed by the user. The device is AC operated at a power setting of 120V / 60Hz 1.2A. BL-7000X is housed in a steel polycarbonate case measuring 395x485x155mm.
6
Processor VP-7000, Light Source BL-7000X, and Image Processing Unit EX-0 are used as a system in conjunction with a compatible video laparoscope or endoscope for visualization of tissue oxygen saturation (StO2) levels.
Comparison of Technological Characteristics
A comparison of the technological characteristics between the subject and predicate devices is provided below, as well as a comparison of the technological characteristics of the subject device to a reference device:
| Subject Device | Predicate Device | Equivalence | |
|---|---|---|---|
| Manufacturer | FUJIFILM Corporation | FUJIFILM Corporation | |
| Device Name | Processor VP-7000 | FUJIFILM Processor VP-7000 | |
| 510(k) Number | K203717 | K192918 | |
| Indications for Use | The VP-7000 unit is used for endoscopic | ||
| observation, diagnosis, treatment, and | |||
| image recording. It is intended to process | |||
| electronic signals transmitted from a video | |||
| endoscope (a video camera in an | |||
| endoscope). |
This product may be used on all patients
requiring endoscopic examination and
when using a Fujinon/FUJIFILM medical
endoscope and light source together with
monitor, recorder and various peripheral
devices. BLI (Blue Light Imaging), LCI
(Linked Color Imaging) and FICE (Flexible
spectral-Imaging Color Enhancement) are
adjunctive tools for gastrointestinal
endoscopic examination which can be
used to supplement Fujifilm white light
endoscopy. BLI, LCI and FICE are not
intended to replace histopathological
sampling as a means of diagnosis.
The Image Processing Unit EX-0 is an
optional module intended for use as an
adjunctive monitor of the hemoglobin
oxygen saturation of blood in superficial
tissue of the endoscopic observation
image area in patients at risk for ischemic
states.
This product may be used on all patients
requiring endoscopic examination when
using a Fujinon/FUJIFILM medical
endoscope, video processor and light
source together with monitor, recorder
and various peripheral devices.
The prospective clinical value of | The VP-7000 unit is used for
endoscopic observation, diagnosis,
treatment, and image recording. It is
intended to process electronic signals
transmitted from a video endoscope
(a video camera in an endoscope).
This product may be used on all
patients requiring endoscopic
examination and when using a
Fujinon/FUJIFILM medical
endoscope and light source together
with monitor, recorder and various
peripheral devices. BLI (Blue Light
Imaging), LCI (Linked Color Imaging)
and FICE (Flexible spectral-Imaging
Color Enhancement) are adjunctive
tools for gastrointestinal endoscopic
examination which can be used to
supplement Fujifilm white light
endoscopy. BLI, LCI and FICE are
not intended to replace
histopathological sampling as a
means of diagnosis. | Both of the
subject and
predicate VP-
7000 are
specifically
indicated for
observation,
diagnosis,
treatment and
image
recording.
The addition
of ability to
adjunctively
monitor
hemoglobin
oxygen
saturation of
blood in
superficial
issue of the
endoscopic
observation
image area in
patients at
risk for
ischemic
states is
consistent
with the
observational
and
diagnostic
intended use
and does not
raise different
questions of
safety or
effectiveness. |
| | been demonstrated in disease states. | | |
| Power Rating | 100-240V AC; | 100-240V AC; | Identical |
| | 50/60Hz; 0.8-0.5A; | 50/60Hz; 0.8-0.5A; | |
| FICE mode | Yes | Yes | Identical |
| BLI mode | Yes | Yes | Identical |
| BLI-bright
mode | Yes | Yes | Identical |
| LCI mode | Yes | Yes | Identical |
| OXEI
(Oxygen
Saturation
Information) | Two-dimensional, color-coded images of
StO2% of the endoscopic observation
image area | Not available | Equivalent |
| Dimensions
WxHxD mm | 390x110x485 mm | 390x110x485 mm | Identical |
| Weight | 9 kg | 9 kg | Identical |
7
| Subject Device | Predicate Device | Equivalence | |
|---|---|---|---|
| Manufacturer | FUJIFILM Corporation | FUJIFILM Corporation | |
| Device Name | Light Source BL-7000X | FUJIFILM Light source BL-7000 | |
| 510(k) | |||
| Number | K203717 | K192918 | |
| Indications | |||
| for Use | The BL-7000X Light Source is used for | ||
| endoscopic observation, diagnosis, | |||
| treatment, and image recording. It is | |||
| intended to provide illumination to an | |||
| endoscope. The light source also | |||
| functions as a pump to supply air through | |||
| the endoscope while inside the body to | |||
| assist in obtaining clear visualization to | |||
| facilitate diagnostic examination. | |||
| This product may be used on all patients | |||
| requiring endoscopic examination and | |||
| when using a Fujinon/FUJIFILM medical | |||
| endoscope and video processor together | |||
| with monitor, recorder and various | |||
| peripheral devices | The BL-7000 Light Source is used for | ||
| endoscopic observation, diagnosis, | |||
| treatment, and image recording. It is | |||
| intended to provide illumination to an | |||
| endoscope. The light source also | |||
| functions as a pump to supply air | |||
| through the endoscope while inside | |||
| the body to assist in obtaining clear | |||
| visualization to facilitate diagnostic | |||
| examination. | |||
| This product may be used on all | |||
| patients requiring endoscopic | |||
| examination and when using a | |||
| Fujinon/FUJIFILM medical | |||
| endoscope and video processor | |||
| together with monitor, recorder and | |||
| various peripheral devices. | Equivalent | ||
| Power Rating | 100-240V AC; | 100-240V AC; | Identical |
| 50/60Hz; 1.2-0.7A; | 50/60Hz; 1.2-0.7A; | ||
| Lamp | 5 LED lamps | 4 LED lamps | Equivalent |
| Dimensions | |||
| WxHxD mm | 395x485x155 mm | 390x485x155 mm | Identical |
| Weight | 16 kg | 12 kg | Equivalent |
8
Performance Data
Software:
Software of the subject device was evaluated according to IEC 62304:2015 and the FDA quidance, "Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices," published May 11, 2005. Cybersecurity controls were developed according to the FDA guidance, "Content of Premarket Submissions for Management of Cybersecurity in Medical Devices," published October 2, 2014.
Electrical Safety/Electromagnetic Compatibility:
Electrical safety, electromagnetic compatibility, and laser safety of the subject device were evaluated using the following standards: ANSI/AAMI ES 60601-1: 2005/(R)2012 and A1:2012, IEC 60601-1- 2:2014, IEC 60601-1-6:2013, IEC 60601-2-18:2009, and IEC 60825-1:2007.
Photobiological safety of the subject device was evaluated according to IEC 62471:2006. The subject device met all exposure limits and was found to not pose a realistic optical hazard.
Performance Testing:
The StO2 measurement function was evaluated via comparative bench testing and animal testing.
-
Bench testing: .
StO2 measurement performance of the subject and reference devices was compared with a dissolved oxygen meter as a gold standard using 7 different blood-based phantoms, simulating the optical properties of different tissues that may be monitored by the subject device. The subject device was used in combination with the Video Laparoscope EL-R740M, Endoscope EC-740T/L and EG-740N to measure the StO2 level. Results demonstrated that the subject device performs comparably to the reference device, T-Stat (K081233), with respect to monitoring StO2 levels. -
. Animal Testing: Three animal studies were conducted: one laparoscopic (Study 1), one endoscopic (Study 2) and one for open surgery (Study 3).
Study 1: A visualization study was conducted to measure the tissue oxygenation saturation (StO2). This study used the subject and reference devices in a laparoscopic manner to look at the serosal surface of the stomach, small intestine, and large intestine. The variability between the subject and reference devices was approximately 29.8%, potentially due to the StO2 variability within the observed tissues. Variability in these measurements has also been reported in the literature. Additionally, limited images were provided to be able to assess the visualization of the device. However, adequate images were provided from this study to show visualization of the device, as well as the StO2 overlay, which were considered acceptable.
Two additional animal studies addressed this variability in oxygenation.
9
Study 2: Tissue oxygen saturation (StO2) in the large intestine and stomach for mucosal tissue was measured endoscopically in 4 female Göttingen minipigs at 11 months of age under general anesthesia with decreased arterial oxygen saturation (SpO2) from 100% to 60%. A correlation of the results with the reference device was compared for performance evaluation. Comparative StO2 measurement performance was evaluated in the swine to simulate clinically-relevant usage of the subject and reference devices. The results of this study demonstrated that the subject device could monitor/measure StO2 levels in a clinically relevant setting.
Study 3: Comparative StO2 measurement performance was evaluated when the subject and reference devices measured StO2 at the same locations under controlled conditions in the open surgery setting where the abdomen was incised and the tissues were exposed and fixed to minimize tissue movement. The StO2 measurement was performed at five parts of the GI tract of each of the three swine including the serosal surface of the stomach, small intestine, and large intestine and the mucosal surface of the stomach and large intestine. Difference in the StO2 readings between the subject and reference devices were analyzed at each part. Measurements of the StO2 were evaluated by the subject and reference devices, which has differences up to 11.4%. The results of this study demonstrated that the subject device measures/monitors the StO2 comparably to the reference device, similar to the bench testing.
The combination of these three studies established that the EX-0 device may be used as an adjunctive monitor of the hemoglobin oxygenation of blood in superficial tissue.
Conclusions
The subject devices FUJIFILM Processor VP-7000, Light Source BL-7000X, and Image Processing Unit EX-0 share the same intended use and substantially similar indications to the predicate device. Bench and animal testing demonstrate that the subject devices are as safe and effective as the predicate device. Thus, FUJIFILM Processor VP-7000, Light Source BL-7000X, and Image Processing Unit EX-0 are substantially equivalent to the listed predicate device.